This test is most useful if any of these apply to you.
This test measures total molybdenum in scalp hair, reported in µg/g. Researchers have studied associations with cholesterol, cancer, and pregnancy outcomes, but hair molybdenum remains an exploratory marker. Its usefulness for diagnosing deficiency, harmful exposure, or disease risk hasn't been established.
Your body gets molybdenum from food and water. Beans and other legumes are rich sources, and grains, nuts, and dairy also contribute. It's absorbed through the gut, stored in several tissues including the liver and kidneys, and cleared mainly in urine.
Inside cells, molybdenum becomes part of a helper molecule needed by four enzyme systems. Enzymes speed up chemical reactions. One molybdenum-dependent enzyme converts sulfite produced during protein breakdown into sulfate, preventing a harmful buildup. Another helps break down purines into uric acid. Purines are components of genetic material found in your cells and many foods. Other molybdenum-dependent reactions help process certain drugs and chemicals.
A rare inherited disorder prevents the body from making the molybdenum-containing helper molecule. It can cause severe seizures and brain injury beginning in infancy. Dietary deficiency is a different problem and is exceptionally rare; a documented case occurred during prolonged intravenous feeding that lacked molybdenum.
Elements can enter hair during growth and accumulate on its surface afterward. Dust, water, sweat, and hair products can all complicate interpretation. For molybdenum, the relationship between the amount in hair and the amount your body has absorbed is poorly established.
Hair growth doesn't make this a validated calendar of exposure. The period represented by hair molybdenum remains uncertain, so a sample cannot reliably be described as your average intake over the previous few months.
In a study of 226 children, hair molybdenum had weak positive correlations with molybdenum in red blood cells and urine. That provides some evidence of a relationship, but it doesn't establish hair as an accurate measure of an individual's internal exposure or nutritional status.
Urine has stronger support for assessing recent molybdenum exposure. Controlled feeding studies show that urinary excretion changes with intake. Even so, a urine result doesn't establish whether your tissues have enough molybdenum or whether exposure has caused harm. Hair, blood, and urine results answer different questions and aren't interchangeable.
In 407 adults across eight Chinese provinces, higher hair molybdenum was associated with higher total cholesterol and greater odds of abnormal cholesterol or triglyceride levels. The study measured hair and blood fats at the same time, so it couldn't establish which came first or whether molybdenum contributed to the difference.
This finding hasn't established that hair testing improves cardiovascular risk assessment or helps choose treatment. Lipid measurements and ApoB have much stronger evidence for those decisions.
Among 175 people who already had coronary artery disease, higher scalp hair molybdenum had a weak association with more severe narrowing of the left anterior descending artery. This artery supplies part of the front of the heart. The study doesn't establish whether hair molybdenum predicts coronary disease in people without a diagnosis.
A larger study measured molybdenum in urine. Across three cohorts totaling 10,818 adults, each doubling of urinary molybdenum was associated with about 13% greater risk of developing heart failure after adjustment for cardiovascular and kidney risk factors. This was an observational association, and it hasn't been established for hair molybdenum.
In a small study of 23 people with stomach cancer and 152 controls, the cancer group had less than half the average hair molybdenum concentration. Controls were selected to be similar in age and sex, but the analysis didn't adequately address diet and other possible explanations. Cancer itself could also change nutrition or mineral handling.
A separate study of 228 people found no statistically significant association between hair molybdenum and glioma after adjustment for other factors. Glioma is a type of brain tumor.
The Sister Study examined toenails, which are a different specimen. Over about 7.5 years, women in the highest third of toenail molybdenum had an estimated 18% lower breast cancer risk than those in the lowest third. The uncertainty around that estimate extended to no difference. It doesn't establish a protective effect or explain what a hair result means.
These studies don't establish a cancer screening role for hair molybdenum. They also provide no basis for choosing a low, middle, or high hair concentration as a health target.
Neural tube defects affect the developing brain or spine and include spina bifida. A case-control study compared 191 affected pregnancies with 261 unaffected pregnancies. Researchers analyzed maternal hair segments intended to represent the period around conception and early pregnancy. Higher hair molybdenum was associated with lower odds of an affected pregnancy after adjustment.
The study didn't establish that the hair measurement accurately captured molybdenum intake during that period, or that increasing molybdenum prevents these birth defects.
In 48 Italian children with autism, higher hair molybdenum was associated with lower IQ scores. Another study of 2,550 children with autism reported that higher hair molybdenum tended to occur with lower hair zinc.
These observations don't establish that molybdenum causes developmental differences. Lower zinc in hair also doesn't establish zinc deficiency. Neither study showed that changing these hair measurements improves development or supports choosing supplements from a hair mineral report.
Research using other specimens shows why the biological meaning of a molybdenum result needs care. In a case-control study of 5,356 Chinese adults, those in the highest quarter of plasma molybdenum had about half the odds of metabolic syndrome compared with the lowest quarter. Metabolic syndrome combines several problems involving waist size, blood pressure, blood sugar, and blood fats.
In a cross-sectional analysis of 15,370 adults, higher urinary molybdenum was associated with a lower prevalence of high blood uric acid and gout. These findings don't show that taking molybdenum lowers uric acid.
A small study comparing 30 women with premature ovarian insufficiency and 31 controls found higher plasma molybdenum in the affected group. Premature ovarian insufficiency involves loss of normal ovarian function before age 40. Experiments investigating a possible mechanism used mice and cultured cells; the human comparison alone couldn't establish causation.
These studies measured plasma or urine. Their associations cannot be transferred to a hair concentration or used to define a desirable hair result.
Consistent collection and use of the same laboratory can reduce some sources of variation. They don't establish whether a rising or falling hair result represents better health. Persistent external contamination can also produce a persistent result, and no validated treatment strategy uses serial hair molybdenum to guide care.
Molybdenum is best interpreted alongside these tests.
Molybdenum is included in these pre-built panels.
Explore possible exposure clues in hair, with guidance on which findings need blood, urine, or environmental testing.